Artivion, Inc. (AORT)
USD 27.79
(-3.84%)
USD 27.79
(-3.84%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.74 Million USD | 356.42% |
| 2022 | 3.24 Million USD | 123.37% |
| 2021 | -13.86 Million USD | -667.92% |
| 2020 | 2.44 Million USD | 236.6% |
| 2019 | -1.78 Million USD | -119.19% |
| 2018 | 9.31 Million USD | 16.84% |
| 2017 | 7.97 Million USD | -63.47% |
| 2016 | 21.82 Million USD | 307.55% |
| 2015 | 5.35 Million USD | -39.42% |
| 2014 | 8.83 Million USD | -36.05% |
| 2013 | 13.82 Million USD | 9.58% |
| 2012 | 12.61 Million USD | 8.32% |
| 2011 | 11.64 Million USD | 17.99% |
| 2010 | 9.86 Million USD | -31.93% |
| 2009 | 14.49 Million USD | 6.17% |
| 2008 | 13.65 Million USD | 64.53% |
| 2007 | 8.29 Million USD | 790.43% |
| 2006 | -1.2 Million USD | 94.02% |
| 2005 | -20.08 Million USD | 7.93% |
| 2004 | -21.81 Million USD | 25.34% |
| 2003 | -29.22 Million USD | 26.88% |
| 2002 | -39.96 Million USD | -420.72% |
| 2001 | 12.46 Million USD | 27.01% |
| 2000 | 9.81 Million USD | 31.46% |
| 1999 | 7.46 Million USD | 9.75% |
| 1998 | 6.8 Million USD | -21.84% |
| 1997 | 8.7 Million USD | 47.46% |
| 1996 | 5.9 Million USD | 90.32% |
| 1995 | 3.1 Million USD | 106.67% |
| 1994 | 1.5 Million USD | 114.29% |
| 1993 | 700 Thousand USD | -36.36% |
| 1992 | 1.1 Million USD | 283.33% |
| 1991 | -600 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 25.31 Million USD | 697.95% |
| 2024 Q2 | 8.26 Million USD | -67.37% |
| 2023 Q2 | 7.67 Million USD | 371.87% |
| 2023 Q4 | 3.17 Million USD | 354.98% |
| 2023 FY | 14.78 Million USD | 356.42% |
| 2023 Q1 | -2.82 Million USD | -187.64% |
| 2023 Q3 | -1.24 Million USD | -116.21% |
| 2022 FY | 3.24 Million USD | 123.37% |
| 2022 Q1 | 1.63 Million USD | 117.52% |
| 2022 Q2 | 801 Thousand USD | -51.04% |
| 2022 Q3 | -4.1 Million USD | -612.61% |
| 2022 Q4 | 3.22 Million USD | 178.45% |
| 2021 Q1 | 1.44 Million USD | -24.45% |
| 2021 Q2 | 1.32 Million USD | -8.51% |
| 2021 Q3 | 14.68 Million USD | 1010.13% |
| 2021 Q4 | -9.33 Million USD | -163.59% |
| 2021 FY | -13.86 Million USD | -667.92% |
| 2020 FY | 2.44 Million USD | 236.6% |
| 2020 Q3 | 3.63 Million USD | 289.27% |
| 2020 Q1 | -1.18 Million USD | -132.69% |
| 2020 Q2 | -1.92 Million USD | -61.75% |
| 2020 Q4 | 1.91 Million USD | -47.33% |
| 2019 Q2 | 6.5 Million USD | 194.88% |
| 2019 FY | -1.78 Million USD | -119.19% |
| 2019 Q1 | 2.2 Million USD | -20.65% |
| 2019 Q3 | 4.7 Million USD | -27.65% |
| 2019 Q4 | 3.63 Million USD | -22.81% |
| 2018 Q2 | 5.4 Million USD | 254.87% |
| 2018 Q4 | 2.77 Million USD | -39.82% |
| 2018 Q3 | 4.61 Million USD | -14.56% |
| 2018 FY | 9.31 Million USD | 16.84% |
| 2018 Q1 | -3.49 Million USD | -1689.74% |
| 2017 Q4 | -195 Thousand USD | -123.52% |
| 2017 Q3 | 829 Thousand USD | -82.69% |
| 2017 FY | 7.97 Million USD | -63.47% |
| 2017 Q2 | 4.78 Million USD | 87.91% |
| 2017 Q1 | 2.54 Million USD | -50.09% |
| 2016 Q2 | 4.58 Million USD | -31.07% |
| 2016 FY | 21.82 Million USD | 307.55% |
| 2016 Q1 | 6.65 Million USD | 37.54% |
| 2016 Q4 | 5.1 Million USD | -6.78% |
| 2016 Q3 | 5.47 Million USD | 19.41% |
| 2015 Q3 | 2.52 Million USD | 653.17% |
| 2015 Q2 | -457 Thousand USD | 70.59% |
| 2015 Q4 | 4.83 Million USD | 91.34% |
| 2015 FY | 5.35 Million USD | -39.42% |
| 2015 Q1 | -1.55 Million USD | -181.57% |
| 2014 Q4 | 1.9 Million USD | -36.82% |
| 2014 Q3 | 3.01 Million USD | 35.69% |
| 2014 Q1 | 1.69 Million USD | -45.87% |
| 2014 Q2 | 2.22 Million USD | 31.01% |
| 2014 FY | 8.83 Million USD | -36.05% |
| 2013 Q1 | 3.31 Million USD | 50.16% |
| 2013 Q2 | 2.81 Million USD | -15.1% |
| 2013 FY | 13.82 Million USD | 9.58% |
| 2013 Q4 | 3.13 Million USD | -31.37% |
| 2013 Q3 | 4.56 Million USD | 62.4% |
| 2012 Q4 | 2.2 Million USD | -25.2% |
| 2012 Q3 | 2.94 Million USD | -49.43% |
| 2012 Q2 | 5.83 Million USD | 257.89% |
| 2012 Q1 | 1.62 Million USD | -44.76% |
| 2012 FY | 12.61 Million USD | 8.32% |
| 2011 Q1 | 2.44 Million USD | -31.71% |
| 2011 Q4 | 2.94 Million USD | 18.15% |
| 2011 Q2 | 3.75 Million USD | 53.29% |
| 2011 Q3 | 2.49 Million USD | -33.46% |
| 2011 FY | 11.64 Million USD | 17.99% |
| 2010 Q4 | 3.58 Million USD | 385.04% |
| 2010 Q1 | 2.68 Million USD | -25.86% |
| 2010 Q2 | 4.85 Million USD | 81.1% |
| 2010 Q3 | -1.25 Million USD | -125.87% |
| 2010 FY | 9.86 Million USD | -31.93% |
| 2009 Q1 | 3.46 Million USD | 23.43% |
| 2009 Q3 | 3.19 Million USD | 75551.35% |
| 2009 FY | 14.49 Million USD | 6.17% |
| 2009 Q4 | 3.61 Million USD | 13.31% |
| 2009 Q2 | 4222.00 USD | -99.88% |
| 2008 Q3 | 3.9 Million USD | -7.09% |
| 2008 Q1 | 2.74 Million USD | -1.29% |
| 2008 FY | 13.65 Million USD | 64.53% |
| 2008 Q2 | 4.2 Million USD | 52.99% |
| 2008 Q4 | 2.8 Million USD | -28.16% |
| 2007 FY | 8.29 Million USD | 790.43% |
| 2007 Q4 | 2.78 Million USD | 70.47% |
| 2007 Q3 | 1.63 Million USD | -30.08% |
| 2007 Q2 | 2.33 Million USD | 50.48% |
| 2007 Q1 | 1.55 Million USD | 164.28% |
| 2006 FY | -1.2 Million USD | 94.02% |
| 2006 Q4 | -2.41 Million USD | -214.2% |
| 2006 Q3 | 2.11 Million USD | 280.04% |
| 2006 Q2 | 556 Thousand USD | 138.13% |
| 2006 Q1 | -1.45 Million USD | 19.93% |
| 2005 FY | -20.08 Million USD | 7.93% |
| 2005 Q1 | -1.32 Million USD | 67.19% |
| 2005 Q3 | -3.47 Million USD | 74.18% |
| 2005 Q4 | -1.82 Million USD | 47.61% |
| 2005 Q2 | -13.46 Million USD | -914.69% |
| 2004 Q4 | -4.04 Million USD | 32.99% |
| 2004 Q2 | -4.7 Million USD | 33.07% |
| 2004 Q1 | -7.03 Million USD | -1.82% |
| 2004 FY | -21.81 Million USD | 25.34% |
| 2004 Q3 | -6.03 Million USD | -28.21% |
| 2003 FY | -29.22 Million USD | 26.88% |
| 2003 Q4 | -6.9 Million USD | -24.14% |
| 2003 Q3 | -5.56 Million USD | 65.4% |
| 2003 Q1 | -673 Thousand USD | 91.28% |
| 2003 Q2 | -16.08 Million USD | -2289.3% |
| 2002 Q4 | -7.71 Million USD | 72.81% |
| 2002 Q3 | -28.36 Million USD | -236.71% |
| 2002 Q2 | -8.42 Million USD | -285.49% |
| 2002 Q1 | 4.54 Million USD | 78.33% |
| 2002 FY | -39.96 Million USD | -420.72% |
| 2001 Q1 | 3.08 Million USD | 42.36% |
| 2001 FY | 12.46 Million USD | 27.01% |
| 2001 Q4 | 2.54 Million USD | -30.43% |
| 2001 Q3 | 3.66 Million USD | 15.45% |
| 2001 Q2 | 3.17 Million USD | 2.89% |
| 2000 FY | 9.81 Million USD | 31.46% |
| 2000 Q4 | 2.16 Million USD | -28.43% |
| 2000 Q1 | 2.1 Million USD | 80.74% |
| 2000 Q2 | 2.55 Million USD | 21.5% |
| 2000 Q3 | 3.02 Million USD | 18.44% |
| 1999 Q2 | 2.4 Million USD | 50.0% |
| 1999 Q1 | 1.6 Million USD | 433.33% |
| 1999 Q4 | 1.16 Million USD | -47.14% |
| 1999 Q3 | 2.2 Million USD | -8.33% |
| 1999 FY | 7.46 Million USD | 9.75% |
| 1998 FY | 6.8 Million USD | -21.84% |
| 1998 Q1 | 2.3 Million USD | 0.0% |
| 1998 Q2 | 2.9 Million USD | 26.09% |
| 1998 Q3 | 2.2 Million USD | -24.14% |
| 1998 Q4 | 300 Thousand USD | -86.36% |
| 1997 Q1 | 1.7 Million USD | 54.55% |
| 1997 FY | 8.7 Million USD | 47.46% |
| 1997 Q3 | 2.7 Million USD | 35.0% |
| 1997 Q4 | 2.3 Million USD | -14.81% |
| 1997 Q2 | 2 Million USD | 17.65% |
| 1996 Q4 | 1.1 Million USD | -45.0% |
| 1996 Q3 | 2 Million USD | 33.33% |
| 1996 Q2 | 1.5 Million USD | 36.36% |
| 1996 Q1 | 1.1 Million USD | 83.33% |
| 1996 FY | 5.9 Million USD | 90.32% |
| 1995 Q2 | 800 Thousand USD | 33.33% |
| 1995 Q3 | 900 Thousand USD | 12.5% |
| 1995 Q4 | 600 Thousand USD | -33.33% |
| 1995 FY | 3.1 Million USD | 106.67% |
| 1995 Q1 | 600 Thousand USD | 200.0% |
| 1994 Q2 | 500 Thousand USD | 66.67% |
| 1994 Q4 | 200 Thousand USD | -60.0% |
| 1994 FY | 1.5 Million USD | 114.29% |
| 1994 Q1 | 300 Thousand USD | 200.0% |
| 1994 Q3 | 500 Thousand USD | 0.0% |
| 1993 Q2 | 300 Thousand USD | -93.62% |
| 1993 FY | 700 Thousand USD | -36.36% |
| 1993 Q1 | 4.7 Million USD | 133.81% |
| 1993 Q3 | 200 Thousand USD | -33.33% |
| 1993 Q4 | 100 Thousand USD | -50.0% |
| 1992 FY | 1.1 Million USD | 283.33% |
| 1992 Q1 | 4.5 Million USD | 138.79% |
| 1992 Q3 | 5.3 Million USD | 0.0% |
| 1992 Q2 | 5.3 Million USD | 17.78% |
| 1992 Q4 | -13.9 Million USD | -362.26% |
| 1991 Q1 | 2.9 Million USD | 0.0% |
| 1991 Q2 | 3.6 Million USD | 24.14% |
| 1991 Q3 | 4.5 Million USD | 25.0% |
| 1991 Q4 | -11.6 Million USD | -357.78% |
| 1991 FY | -600 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 99.911% |
| Allurion Technologies Inc. | -78.07 Million USD | 107.354% |
| Avanos Medical, Inc. | 4.2 Million USD | -36.714% |
| Butterfly Network, Inc. | -145.61 Million USD | 103.943% |
| Butterfly Network, Inc. | -145.61 Million USD | 103.943% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | 98.504% |
| Boston Scientific Corporation | 2.34 Billion USD | 99.755% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 137.821% |
| CONMED Corporation | 130.78 Million USD | 95.61% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 99.626% |
| Paragon 28, Inc. | -37.3 Million USD | 115.39% |
| Glaukos Corporation | -128.7 Million USD | 104.462% |
| Globus Medical, Inc. | 133.14 Million USD | 95.687% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 114.258% |
| Integer Holdings Corporation | 167.33 Million USD | 96.568% |
| Medtronic plc | 5.14 Billion USD | 99.888% |
| Nevro Corp. | -99.3 Million USD | 105.782% |
| Owlet, Inc. | -28.63 Million USD | 120.054% |
| Penumbra, Inc. | 73.55 Million USD | 92.193% |
| Vicarious Surgical Inc. | -80.66 Million USD | 107.118% |
| Smith & Nephew plc | 425 Million USD | 98.649% |
| Sonendo, Inc. | -57.74 Million USD | 109.944% |
| STERIS plc | 836.11 Million USD | 99.313% |
| Stryker Corporation | 3.88 Billion USD | 99.852% |
| Vapotherm, Inc. | -39.08 Million USD | 114.693% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 99.551% |